Have a personal or library account? Click to login

Influence of education training in patients with type 2 diabetes in the improvement of lifestyle and biochemical characteristics: a randomized controlled trial

Open Access
|Dec 2019

References

  1. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia Report of a WHO/IDF Consultation. WHO; 2006. https://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabe-tes_new.pdf Accessed May 5, 2019.
  2. International Diabetes Federation. Diabetes Atlas. 7th edn. International Diabetes Federation; 2015. https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/13-diabetes-atlas-seventh-edition.html Accessed May 5, 2019.
  3. Ma R, Chan J. Metabolic complications of obesity. In: Williams G, Fruhbeck G, eds. Obesity: Science to Practice. United Kingdom: John Wiley & Sons Ltd; 2009:235-270.
  4. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham study. J Am Med Assoc. 1979;241:2035-2038.10.1001/jama.1979.03290450033020
  5. Mbanya JC, Kengne AP, Assah F. Diabetes care in Africa. Lancet. 2006;368:1628-1629.10.1016/S0140-6736(06)69673-617098063
  6. Kocur I, Resnikoff S. Visual impairment and blindness in Europe and their prevention. Br J Ophthalmol. 2002;86:716-722.1208473510.1136/bjo.86.7.716
  7. Boulton AJM. The diabetic foot: a global view. Diabetes Metab Res Rev. 2000;16:S2-S5.10.1002/1520-7560(200009/10)16:1+<;::AID-DMRR105>3.0.CO;2-N11054879
  8. Oyibo SO, Jude EB, Tarawneh I, et al. The effects of ulcer size and site, patient’s age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med. 2001; 18:133-138.10.1046/j.1464-5491.2001.00422.x11251677
  9. Ma RC, Kong AP, Chan N, Tong PC, Chan JC. Drug-induced endocrine and metabolic disorders. Drug Saf. 2007;30:215-245.1734343010.2165/00002018-200730030-00005
  10. Expert Committee Report on the Diagnosis of Diabetes. The role of glycated haemoglobin (A1C) assay in the diagnosis of diabetes in non-pregnant persons. Diabetes Care. 2009;32:1327-1334.
  11. Barr RG, Nathan DM, Meigs JB, Singer DE. Tests of glycemia for the diagnosis of diabetes mellitus. Ann Intern Med. 2002;137:263-272.10.7326/0003-4819-137-4-200208200-00011
  12. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580-591.1825639310.1056/NEJMoa0706245
  13. Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560-2572.1853991610.1056/NEJMoa0802987
  14. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-393.1255654110.1056/NEJMoa021778
  15. Yousefzadeh G, Shokoohi M, Najafipour H. Inadequate control of diabetes and metabolic indices among diabetic patients: a population based study from the Kerman Coronary Artery Disease Risk Study (KERCADRS). Int J Health Policy Manage. 2014;4:271-277.10.15171/ijhpm.2015.06
  16. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577-1589.10.1056/NEJMoa080647018784090
  17. Shrivastava SR, Shrivastava PS, Ramasamy J. Role of self-care in management of diabetes mellitus. J Diabetes Metab Disord. 2013;12:14.10.1186/2251-6581-12-1423497559
  18. Garay-Sevilla ME, Malacara JM, Gutierrez-Roa A, Gonzalez E. Denial of disease in type 2 diabetes mellitus: its influence on metabolic control and associated factors. Diabet Med. 1999;16:238-244.1022757010.1046/j.1464-5491.1999.00033.x
  19. Watanabe M, Yamaoka K, Yokotsuka M, Tango T. Randomized controlled trial of a new dietary education program to prevent type 2 diabetes in a high-risk group of Japanese male workers. Diabetes Care. 2003;26:3209-3214.10.2337/diacare.26.12.3209
  20. Adachi M, Yamaoka K, Watanabe M, et al. Effects of lifestyle education program for type 2 diabetes patients in clinics: a cluster randomized controlled trial. BMC Public Health. 2013;13:467.2367273310.1186/1471-2458-13-467
  21. Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomarker Insights. 2016;11:95-104.27398023
  22. Glasgow RE, Hiss RG, Anderson RM, et al. Report of the health care delivery work group: behavioral research related to the establishment of a chronic disease model for diabetes care. Diabetes Care. 2001;24:124-130.1119421710.2337/diacare.24.1.124
  23. Naqvi S, Naveed S, Ali Z, et al. Correlation between glycated hemoglobin and triglyceride level in type 2 diabetes mellitus. Cureus. 2017;9:e1347.28713663
  24. Campbell NR, Gilbert RE, Leiter LA, et al. Hypertension in people with type 2 diabetes: update on pharmacologic management. Canadian Family Physician Medecin de famille canadien. 2011;57:997-1002, e347-353.21918140
  25. VinodMahato R, Gyawali P, Raut PP, et al. Association between glycaemic control and serum lipid profile in type 2 diabetic patients: glycated haemoglobin as a dual biomarker. Biomed Res. 2011;22:375-380.
  26. Alam AY, Qureshi AA, Adil MM, Ali H. Comparative study of knowledge, attitude and practices among antenatal care facilities utilizing and non-utilizing women. J Pak Med Assoc. 2005;55:53-56.15813628
DOI: https://doi.org/10.2478/FON-2019-0046 | Journal eISSN: 2544-8994 | Journal ISSN: 2097-5368
Language: English
Page range: 293 - 299
Submitted on: May 20, 2019
Accepted on: Aug 31, 2019
Published on: Dec 31, 2019
Published by: Shanxi Medical Periodical Press
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Alida Ramaj, Fatjona Kamberi, published by Shanxi Medical Periodical Press
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.